Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5997)
All Articles published online
|
Publishing Process of This Article
|
Dec 21, 2014 (publication date) through May 3, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Wen F, Yao K, Du ZD, He XF, Zhang PF, Tang RL, Li Q. Cost-effectiveness analysis of colon cancer treatments from MOSIAC and No. 16968 trials. World J Gastroenterol 2014; 20(47): 17976-17984 [PMID: 25548497 DOI: 10.3748/wjg.v20.i47.17976] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v20/i47/17976.htm |
| Number | Citing Articles |
| 1 |
Mina Iwai, Michio Kimura, Eiseki Usami, Tomoaki Yoshimura, Hitomi Teramachi. Pharmaco-economic analysis of adjuvant chemotherapy for stage II and III colorectal cancer. Molecular and Clinical Oncology 2017; 6(5): 794 doi: 10.3892/mco.2017.1218
|
| 2 |
Adam J. N. Raymakers, David Cameron, Scott Tyldesley, Dean A. Regier. Cost-Effectiveness Analysis of Stereotactic Ablative Body Radiotherapy for the Treatment of Oligometastatic Tumors versus Standard of Care. Current Oncology 2021; 28(3): 1857 doi: 10.3390/curroncol28030172
|
| 3 |
XiaoXia Wei, JiaQin Cai, Hong Sun, Na Li, Chenxia Xu, Guifeng Zhang, Yuxia Sui, Jie Zhuang, Bin Zheng. Cost–effectiveness analysis of UGT1A1*6/*28 genotyping for preventing FOLFIRI-induced severe neutropenia in Chinese colorectal cancer patients. Pharmacogenomics 2019; 20(4): 241 doi: 10.2217/pgs-2018-0138
|
| 4 |
Yumei Zhang, Zhiyu Chen, Jin Li. The current status of treatment for colorectal cancer in China. Medicine 2017; 96(40): e8242 doi: 10.1097/MD.0000000000008242
|
| 5 |
Qiuji Wu, Pengfei Zhang, Xinyuan Wang, Mengxi Zhang, Weiting Liao, Qiu Li. Cost-effectiveness of Capecitabine + Irinotecan Versus Leucovorin + Fluorouracil + Irinotecan in the Second-line Treatment of Metastatic Colorectal Cancer in China. Clinical Therapeutics 2020; 42(11): 2148 doi: 10.1016/j.clinthera.2020.08.015
|
| 6 |
Jiehua Cheng, Yu Zhang, Ailin Zhong, Miao Tian, Guanyang Zou, Xiaping Chen, Hongxing Yu, Fujian Song, Shangcheng Zhou. Quality of Health Economic Evaluations in Mainland China: A Comparison of Peer-Reviewed Articles in Chinese and in English. Applied Health Economics and Health Policy 2022; 20(1): 35 doi: 10.1007/s40258-021-00674-0
|
| 7 |
Yat Hang To, Peter Gibbs, Jeanne Tie, Maarten IJzerman, Koen Degeling. Health economic evidence for adjuvant chemotherapy in stage II and III colon cancer: a systematic review. Cost Effectiveness and Resource Allocation 2023; 21(1) doi: 10.1186/s12962-023-00422-2
|
| 8 |
Masato Nakamura, Yasuhide Yamada, Kei Muro, Keiichi Takahashi, Hideo Baba, Yasutsuna Sasaki, Yoshito Komatsu, Taroh Satoh, Hideyuki Mishima, Masahiko Watanabe, Yuh Sakata, Satoshi Morita, Yasuhiro Shimada, Kenichi Sugihara. The SOFT trial: a Phase III study of the dihydropyrimidine dehydrogenase inhibitory fluoropyrimidine S-1 and oxaliplatin (SOX) plus bevacizumab as first-line chemotherapy for metastatic colorectal cancer. Future Oncology 2015; 11(10): 1471 doi: 10.2217/fon.15.59
|
| 9 |
Philip Q. Ding, Flora Au, Winson Y. Cheung, Steven J. Heitman, Richard Lee-Ying. Cost-Effectiveness of Surveillance after Metastasectomy of Stage IV Colorectal Cancer. Cancers 2023; 15(16): 4121 doi: 10.3390/cancers15164121
|
| 10 |
Xia Zhang, Rui-Hua Yi, Xia-Yun Jin, Hong-Juan Zheng, Xi-Feng Xu, Qing-Hua Wang, Jian-Fei Fu. Cost-effectiveness of different chemotherapy strategies for high-risk stage II colon cancer. World Chinese Journal of Digestology 2023; 31(17): 742 doi: 10.11569/wcjd.v31.i17.742
|
| 11 |
Terumi Kaishima, Tomoyuki Akita, Masayuki Ohisa, Kazuaki Sakamune, Akemi Kurisu, Aya Sugiyama, Hiroshi Aikata, Kazuaki Chayama, Junko Tanaka. Cost‐effectiveness analyses of anti‐hepatitis C virus treatments using quality of life scoring among patients with chronic liver disease in Hiroshima prefecture, Japan. Hepatology Research 2018; 48(7): 509 doi: 10.1111/hepr.13053
|